Mohamed Namazie bin A. M. Ibrahim
Directeur/Membre du Conseil chez eMedAsia Sdn Bhd
Postes actifs de Mohamed Namazie bin A. M. Ibrahim
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
eMedAsia Sdn Bhd
 eMedAsia Sdn Bhd Internet Software/ServicesTechnology Services Part of Hong Seng Consolidated Bhd., eMedAsia Sdn Bhd is a Malaysian healthcare company founded in 2020. The company is based in Kuala Lumpur, Malaysia and offers affordable health screening packages at partner clinics, as well as Covid-19 RTK and PCR tests. Bhd. on February 23, 2021 for $1.28 million. eMedAsia was acquired by HS Bio Sdn. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Mohamed Namazie bin A. M. Ibrahim
Statistiques
Internationale
| Malaisie | 2 |
Opérationnelle
| Director/Board Member | 1 |
Sectorielle
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
eMedAsia Sdn Bhd
eMedAsia Sdn Bhd Internet Software/ServicesTechnology Services Part of Hong Seng Consolidated Bhd., eMedAsia Sdn Bhd is a Malaysian healthcare company founded in 2020. The company is based in Kuala Lumpur, Malaysia and offers affordable health screening packages at partner clinics, as well as Covid-19 RTK and PCR tests. Bhd. on February 23, 2021 for $1.28 million. eMedAsia was acquired by HS Bio Sdn. | Technology Services |
